INSMED INC Increase (Decrease) in Prepaid Expense
INSMED INC (INSM) reported Increase (Decrease) in Prepaid Expense of -$352.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2011-11-09
- INSMED INC increase (decrease) in prepaid expense for the quarter ending 2011-09-30 was $12.00K.
- INSMED INC increase (decrease) in prepaid expense for the quarter ending 2010-09-30 was -$23.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month |
|---|---|---|---|
| 2011-09-30 | $12.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | -$352.00K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | -$364.00K 10-Q/A · filed 2011-08-08 | ||
| 2010-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | -$205.00K 10-Q · filed 2011-11-09 | |
| 2010-06-30 | -$182.00K 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |